Cemented versus Cementless Total Hip Arthroplasty in Paget's Disease of Bone: A Systematic Review

Abstract

The purpose of this study is to systematically review the clinical evidence for the use of cemented and cementless total hip arthroplasty (THA) in Paget's disease of bone (PDB), and to ascertain whether any difference exists in clinical outcomes between the two implant types. MEDLINE, EMBASE, and the Cochrane Library databases were searched in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. The quality of the studies was assessed using the methodological index for nonrandomized studies (MINORS) checklist. The reported clinical outcomes were evaluated using risk ratio (RR) with a p < 0.05 considered as statistically significant. Thirteen clinical studies with 444 primary THAs were included in this review. Cementless THA resulted in lower rates of aseptic loosening and lower rates of revision due to aseptic loosening (p < 0.05), but there was no overall statistically significant increase in the incidence of revision in the cemented THAs (p = 0.21). The postoperative Harris hip score was similar between both the groups. Also, the presence of heterotrophic ossification was similar in both the groups. Functional outcomes and survivorship were equivalent using either cementless or cemented components, with a similar rate of overall revisions. However, cementless components resulted in a decreased incidence of aseptic loosening and revision due to aseptic loosening. The current literature consists of a low level of evidence, level IV, which limits the conclusion of this study.

Keywords

arthroplasty - hip - Paget's disease of bone - systematic review

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Note

This study has been presented at the British Hip Society, London between March 2 and 3, 2017.

• References

• 1 Cooper C, Harvey NC, Dennison EM, van Staa TP. Update on the epidemiology of Paget's disease of bone. J Bone Miner Res 2006; 21 (Suppl. 02) 3-8
• 2 Parvizi J, Klein GR, Sim FH. Surgical management of Paget's disease of bone. J Bone Miner Res 2006; 21 (Suppl. 02) 75-82
• 3 Guyer PB, Chamberlain AT, Ackery DM, Rolfe EB. The anatomic distribution of osteitis deformans. Clin Orthop Relat Res 1981; (156) 141-144
• 4 NCHS data brief. Center for disease control and prevention (2015). Available at: https://www.cdc.gov/nchs/data/databriefs/db186.pdf . Accessed June 5, 2016
• 5 Lewallen DG. Hip arthroplasty in patients with Paget's disease. Clin Orthop Relat Res 1999; (369) 243-250
• 6 Stauffer RN, Sim FH. Total hip arthroplasty in Paget's disease of the hip. J Bone Joint Surg Am 1976; 58 (04) 476-478
• 7 Hadjipavlou A, Lander P, Srolovitz H. Pagetic arthritis. Pathophysiology and management. Clin Orthop Relat Res 1986; (208) 15-19
• 8 Merkow RL, Pellicci PM, Hely DP, Salvati EA. Total hip replacement for Paget's disease of the hip. J Bone Joint Surg Am 1984; 66 (05) 752-758
• 9 McDonald DJ, Sim FH. Total hip arthroplasty in Paget's disease. A follow-up note. J Bone Joint Surg Am 1987; 69 (05) 766-772
• 10 Engelhardt P, Bodle A. Hüftendoprothesen beim Morbus Paget [Hip endoprostheses in Paget's disease]. Orthopade 1988; 17 (05) 404-406
• 11 Ludkowski P, Wilson-MacDonald J. Total arthroplasty in Paget's disease of the hip. A clinical review and review of the literature. Clin Orthop Relat Res 1990; (255) 160-167
• 12 Sochart DH, Porter ML. Charnley low-friction arthroplasty for Paget's disease of the hip. J Arthroplasty 2000; 15 (02) 210-219
• 13 Kirsh G, Kligman M, Roffman M. Hydroxyapatite-coated total hip replacement in Paget's disease: 20 patients followed for 4-8 years. Acta Orthop Scand 2001; 72 (02) 127-132
• 14 Parvizi J, Schall DM, Lewallen DG, Sim FH. Outcome of uncemented hip arthroplasty components in patients with Paget's disease. Clin Orthop Relat Res 2002; (403) 127-134
• 15 Wegrzyn J, Pibarot V, Chapurlat R, Carret JP, Béjui-Hugues J, Guyen O. Cementless total hip arthroplasty in Paget's disease of bone: a retrospective review. Int Orthop 2010; 34 (08) 1103-1109
• 16 Imbuldeniya AM, Tai SM, Aboelmagd T, Walter WL, Walter WK, Zicat BA. Cementless hip arthroplasty in Paget's disease at long-term follow-up (average of 12.3 years). J Arthroplasty 2014; 29 (05) 1063-1066
• 17 Liberati A, Altman DG, Tetzlaff J. , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700
• 18 Howick J, Chalmers I, Glasziou P. , et al. The 2011 Oxford CEBM Evidence Levels of Evidence (Introductory document). Available at: http://www.cebm.net/index.aspx?o=5653
• 19 Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003; 73 (09) 712-716
• 20 Ha'Eri GB, Schatzker J. Total replacement of the hip joint affected by Paget's diseases. Can J Surg 1978; 21 (04) 370-372
• 21 Calderoni P, Ferruzzi A, Andreoli I, Gualtieri G. Hip arthroplasty in coxarthrosis secondary to Paget's disease. Chir Organi Mov 2002; 87 (01) 43-48
• 22 Annual Report 2015. Australian Orthopaedic Association National Joint Replacement Registry 2015. Available at: https://aoanjrr.sahmri.com/annual-reports-2015 . Accessed July 5, 2016
• 23 Zagaja GP, Cromie WJ. Heterotopic bone formation in association with pelvic fracture and urethral disruption. J Urol 1999; 161 (06) 1950-1953
• 24 Robey PG, Bianco P. The role of osteogenic cells in the pathophysiology of Paget's disease. J Bone Miner Res 1999; 14 (Suppl. 02) 9-16
• 25 Koulovaris P, Sheer D, Sculco T. Incidence of heterotopic ossification in patients receiving radiation therapy following total hip replacement. Adv Orthop Surg 2014; 2014: 1-4
• 26 Maloney WJ, Krushell RJ, Jasty M, Harris WH. Incidence of heterotopic ossification after total hip replacement: effect of the type of fixation of the femoral component. J Bone Joint Surg Am 1991; 73 (02) 191-193
• 27 Nayak KN, Mulliken B, Rorabeck CH, Bourne RB, Woolfrey MR. Prevalence of heterotopic ossification in cemented versus noncemented total hip joint replacement in patients with osteoarthrosis: a randomized clinical trial. Can J Surg 1997; 40 (05) 368-374
• 28 Purtill JJ, Eng K, Rothman RH, Hozack WJ. Heterotopic ossification. Incidence in cemented versus cementless total hip arthroplasty. J Arthroplasty 1996; 11 (01) 58-63
• 29 Abdulkarim A, Ellanti P, Motterlini N, Fahey T, O'Byrne JM. Cemented versus uncemented fixation in total hip replacement: a systematic review and meta-analysis of randomized controlled trials. Orthop Rev (Pavia) 2013; 5 (01) e8